Dec 20, 2019 - Gilead (GILD) files an NDA for filgotinib with the FDA for the treatment of adults with moderate-to-severe rheumatoid arthritis.
Dec 19, 2019 - The Zacks Analyst Blog Highlights: Johnson & Johnson, Eli Lilly, PNC Financial, EOG Resources and Archer-Daniels-Midland
Dec 19, 2019 - FDA grants priority review to Pfizer's (PFE) sNDA seeking approval of Braftovi in combination with Erbitux as a treatment for advanced colorectal cancer.
Dec 18, 2019 - Top Stock Reports for Johnson & Johnson, Eli Lilly & PNC Financial
Dec 18, 2019 - Eli Lilly's (LLY) stock up on Tuesday after it provides an upbeat financial guidance for the next year.
Dec 17, 2019 - Over the past couple of years, patents have expired on a few of Eli Lilly's (LLY) key drugs, most no
Dec 16, 2019 - Lilly's (LLY) regulatory application seeking approval for cancer drug, Cyramza, in combination with erlotinib for treating EGFR-mutated NSCLC in first-line setting gets positive CHMP opinion for approval in EU.
Dec 13, 2019 - This week two deals grab headlines in the pharma space. Merck (MRK) offers to buy ArQule for $2.7 billion while Sanofi (SNY) signs a definitive deal to purchase Synthorx for $2.5 billion
Dec 12, 2019 - Lilly (LLY) initiates a phase III study on its oral RET inhibitor, selpercatinib, in treatment-naive, RET fusion-positive NSCLC patients.
Dec 02, 2019 - These companies have some important presentations scheduled for the last big oncology conference of the year.